Search research articles
Contact Us
Filters
Showing results (1-10 of 40) with videos related to
Page
of 4
Sort By:
Current Opinion in Virology
|
May 24, 2014
Resistance to hepatitis C virus protease inhibitors
Tara L Kieffer, Shelley George
Current Opinion in HIV and AIDS
|
April 18, 2009
Update on HIV-1 viral load blips
Richard E Nettles, Tara L Kieffer
The Journal of Antimicrobial Chemotherapy
|
November 12, 2009
Viral resistance to specifically targeted antiviral therapies for hepatitis C (STAT-Cs)
Tara L Kieffer, Ann D Kwong, Gaston R Picchio
Microbes and Infection
|
May 10, 2003
Francisella novicida LPS has greater immunobiological activity in mice than F. tularensis LPS, and contributes to F. novicida murine pathogenesis
Tara L Kieffer, Siobhan Cowley, Francis E Nano, et al.
The Journal of Antimicrobial Chemotherapy
|
March 15, 2006
HIV-1 viral load blips are of limited clinical significance
Patricia K Lee, Tara L Kieffer, Robert F Siliciano, et al.
Infection and Immunity
|
March 16, 2002
In vivo clearance of an intracellular bacterium, Francisella tularensis LVS, is dependent on the p40 subunit of interleukin-12 (IL-12) but not on IL-12 p70
Karen L Elkins, Allison Cooper, Susan M Colombini, et al.
Journal of Virology
|
August 7, 2002
Molecular characterization of preintegration latency in human immunodeficiency virus type 1 infection
Theodore C Pierson, Yan Zhou, Tara L Kieffer, et al.
Journal of Virology
|
January 15, 2005
G-->A hypermutation in protease and reverse transcriptase regions of human immunodeficiency virus type 1 residing in resting CD4+ T cells in vivo
Tara L Kieffer, Patty Kwon, Richard E Nettles, et al.
Journal of Virology
|
March 22, 2002
Intrinsic stability of episomal circles formed during human immunodeficiency virus type 1 replication
Theodore C Pierson, Tara L Kieffer, Christian T Ruff, et al.
Journal of Pharmacokinetics and Pharmacodynamics
|
August 21, 2015
Modeling population heterogeneity in viral dynamics for chronic hepatitis C infection: Insights from Phase 3 telaprevir clinical studies
Eric L Haseltine, Holly Kimko, Haobin Luo, et al.
Page
of 4
Search research articles
Search
Showing results (1-10 of 40) with videos related to
Sort By:
Page
of 4
Current Opinion in Virology
|
May 24, 2014
Resistance to hepatitis C virus protease inhibitors
Tara L Kieffer, Shelley George
Current Opinion in HIV and AIDS
|
April 18, 2009
Update on HIV-1 viral load blips
Richard E Nettles, Tara L Kieffer
The Journal of Antimicrobial Chemotherapy
|
November 12, 2009
Viral resistance to specifically targeted antiviral therapies for hepatitis C (STAT-Cs)
Tara L Kieffer, Ann D Kwong, Gaston R Picchio
Microbes and Infection
|
May 10, 2003
Francisella novicida LPS has greater immunobiological activity in mice than F. tularensis LPS, and contributes to F. novicida murine pathogenesis
Tara L Kieffer, Siobhan Cowley, Francis E Nano, et al.
The Journal of Antimicrobial Chemotherapy
|
March 15, 2006
HIV-1 viral load blips are of limited clinical significance
Patricia K Lee, Tara L Kieffer, Robert F Siliciano, et al.
Infection and Immunity
|
March 16, 2002
In vivo clearance of an intracellular bacterium, Francisella tularensis LVS, is dependent on the p40 subunit of interleukin-12 (IL-12) but not on IL-12 p70
Karen L Elkins, Allison Cooper, Susan M Colombini, et al.
Journal of Virology
|
August 7, 2002
Molecular characterization of preintegration latency in human immunodeficiency virus type 1 infection
Theodore C Pierson, Yan Zhou, Tara L Kieffer, et al.
Journal of Virology
|
January 15, 2005
G-->A hypermutation in protease and reverse transcriptase regions of human immunodeficiency virus type 1 residing in resting CD4+ T cells in vivo
Tara L Kieffer, Patty Kwon, Richard E Nettles, et al.
Journal of Virology
|
March 22, 2002
Intrinsic stability of episomal circles formed during human immunodeficiency virus type 1 replication
Theodore C Pierson, Tara L Kieffer, Christian T Ruff, et al.
Journal of Pharmacokinetics and Pharmacodynamics
|
August 21, 2015
Modeling population heterogeneity in viral dynamics for chronic hepatitis C infection: Insights from Phase 3 telaprevir clinical studies
Eric L Haseltine, Holly Kimko, Haobin Luo, et al.
Page
of 4